STAAR Surgical Company
STAA
$26.27
$0.240.92%
NASDAQ
| 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | |
|---|---|---|---|---|---|
| Revenue | 230.59M | 224.45M | 279.13M | 313.90M | 341.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 230.59M | 224.45M | 279.13M | 313.90M | 341.22M |
| Cost of Revenue | 60.26M | 63.51M | 72.58M | 74.32M | 72.57M |
| Gross Profit | 170.33M | 160.94M | 206.55M | 239.58M | 268.66M |
| SG&A Expenses | 187.83M | 194.16M | 201.54M | 202.39M | 192.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 293.27M | 305.88M | 323.95M | 326.25M | 313.87M |
| Operating Income | -62.68M | -81.43M | -44.81M | -12.35M | 27.36M |
| Income Before Tax | -91.95M | -97.58M | -61.33M | -9.05M | 35.02M |
| Income Tax Expenses | 4.42M | -2.31M | 9.75M | 11.16M | 13.25M |
| Earnings from Continuing Operations | -96.37 | -95.27 | -71.08 | -20.21 | 21.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.37M | -95.27M | -71.08M | -20.21M | 21.78M |
| EBIT | -62.68M | -81.43M | -44.81M | -12.35M | 27.36M |
| EBITDA | -53.99M | -72.99M | -36.82M | -5.46M | 33.09M |
| EPS Basic | -1.95 | -1.93 | -1.44 | -0.41 | 0.44 |
| Normalized Basic EPS | -0.74 | -0.88 | -0.49 | -0.11 | 0.46 |
| EPS Diluted | -1.96 | -1.93 | -1.44 | -0.41 | 0.44 |
| Normalized Diluted EPS | -0.74 | -0.88 | -0.49 | -0.12 | 0.46 |
| Average Basic Shares Outstanding | 197.76M | 197.33M | 196.94M | 196.50M | 196.05M |
| Average Diluted Shares Outstanding | 198.68M | 197.86M | 198.15M | 197.72M | 197.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |